39.92 USD
▲+0.35+3.45%
盘后 39.91 +3.42%
2026-08-03
市值
$1.94B
市盈率
—
EPS
-2.73
股息率
—
52 周区间
15.86 – 43.93
成交量
734.38K
Beta
1.57
目标价
44.75
52W 低 15.8652W 高 43.93
价格走势
公司简介
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology; Mitomycin a generic drug used off-label as an adjuvant chemotherapy for the treatment of low-grade NMIBC after trans-urethral resection of bladder tumor; Zusduri, a sustained-release formulation of mitomycin for the treatment of non-muscle invasive bladder cancer (NMIBC); and Jelmyto for pyelocal...